Core Insights - NeOnc Technologies Holdings, Inc. has been included in the Russell Microcap® Index, which is a significant recognition of the company's growth and commitment to shareholder value [1][3] - The Russell Microcap® Index includes companies with an average market capitalization of approximately $640 million, covering stocks ranging from about $30 million to $3 billion [3][4] - NeOnc is focused on advancing its Phase II clinical trials for CNS cancers and expanding into the MENA region through a proposed partnership with Quazar [3] Company Overview - NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company dedicated to developing treatments for central nervous system cancers and disorders [1][6] - The company utilizes the NEO™ drug development platform, which has produced a portfolio of novel drug candidates with patent protections extending to 2038 [6] - NeOnc's therapeutics, NEO100™ and NEO212™, are currently in Phase II human clinical trials and have received FDA Fast-Track and Investigational New Drug (IND) status [6] Industry Context - The Russell US Indexes reconstitution ranks the 4,000 largest US stocks by total market capitalization, and membership in the Russell Microcap® Index is valid for one year [2][4] - Russell indexes are widely utilized by investment managers and institutional investors, serving as benchmarks for approximately $10.6 trillion in assets as of June 2024 [4]

Core Viewpoint - Zeo Energy Corp. has been included in the Russell Microcap Index, marking a significant milestone for the company as it continues to enhance its operational capabilities and expand through acquisitions [1][3]. Company Overview - Zeo Energy Corp. is a Florida-based provider of residential solar and energy efficiency solutions, focusing on high-growth markets with limited competition [5]. - The company aims to help customers reduce energy bills and promote sustainability through its vertically integrated offerings [5]. Index Inclusion Details - The Russell Microcap Index includes the 4,000 largest US stocks ranked by market capitalization, and membership lasts for one year [2]. - Inclusion in the Russell Microcap Index provides automatic inclusion in relevant growth and value style indexes, which are widely utilized by investment managers and institutional investors [2][3]. Market Impact - Russell indexes serve as benchmarks for approximately $10.6 trillion in assets as of June 2024, indicating the significance of Zeo's inclusion for attracting broader investment community attention [3].

Core Points - Nukkleus Inc. has been added to the Russell Microcap Index effective June 30, 2025, enhancing its visibility among institutional investors [1][4] - The company is pursuing a disciplined global M&A strategy in the Aerospace & Defense industry, focusing on acquiring mission-critical suppliers [6][7] - Nukkleus plans to acquire a 51% controlling interest in Star 26 Capital Inc., which supplies defense-related products for Israel's "Iron Dome" [2] Company Overview - Nukkleus Inc. focuses on acquiring and scaling suppliers in the defense, aerospace, and advanced manufacturing sectors, targeting Tier 2 and Tier 3 companies [6] - The company aims to modernize and expand strategic suppliers to support dual-use innovation and resilient supply chains [6] - Nukkleus combines organic growth with disciplined M&A to position itself at the core of the 21st-century defense industrial strategy [7] Industry Context - The Russell US Indexes reconstitution captures the 4,000 largest US stocks, ranking them by total market capitalization, with membership in the Russell Microcap Index lasting for one year [3] - Russell indexes are widely used by investment managers and institutional investors, serving as benchmarks for approximately $10.6 trillion in assets as of June 2024 [4]